The Recall Desk
HighFDA (Devices)·Z-0093-2023·Announced 2022-10-26

Siemens N Antiserum to Human IgG Recall for High-Dose Performance Failure

Siemens Healthcare Diagnostics recalls N Antiserum to Human IgG reagent for laboratory analyzers because it does not meet expected High-Dose Hook Effect performance specifications for IgG measurements in certain sample types.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Class II medical device recall for a diagnostic reagent with performance specification failure. The product presents a risk of harm through inaccurate test results in clinical diagnostics. No illnesses or injuries have been reported, but the deficiency in a clinical diagnostic test meets the rubric criterion of risk-of-harm products where injury has not yet been reported.

Plain-English summary

Siemens Healthcare Diagnostics is recalling N Antiserum to Human IgG (2mL variant) intended for use with BN II System and BN ProSpec System analyzers.

The reagent is not meeting expected High-Dose Hook Effect performance specifications. Specifically, it is failing to meet expected performance thresholds of up to 648 mg/L for IgGU (urine) and up to 2290 mg/L for IgGC (cerebrospinal fluid). This performance deficiency may affect the accuracy of IgG measurements at high concentrations.

The affected lot is 153088, with distribution nationwide. Future lots may also be impacted and will include an instruction note in the reagent package if affected.

Laboratory facilities using this reagent should follow guidance from Siemens Healthcare Diagnostics regarding continued use and appropriate corrective actions.

The recalled product

Product
N Antiserum to Human IgG, 2mL Variant for BN II System and BN ProSpec System-IVD Siemens Material Number (SMN): 10446297
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC
Hazard
  • diagnostic-failure
  • measurement-inaccuracy

Distribution

Distributed nationwide across the United States.